Pseudomonas aeruginosa deficient in 8-oxodeoxyguanine repair system shows a high frequency of resistance to ciprofloxacin

FEMS Microbiology Letters

Volumn 290, Issue 2, 2009, Pages 217-226

  Morero, Natalia R ^a   Argaraña, Carlos E ^a  

^a Centro de Investigaciones En Quimica Biologica de Cordoba   (Argentina)

Author keywords

Ciprofloxacin resistance; MutM; MutT; MutY; NfxB; Pseudomonas aeruginosa

Indexed keywords

8 HYDROXYGUANINE; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; HYDROGEN PEROXIDE; PARAQUAT;

ANTIBIOTIC RESISTANCE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; GENE; GENE FREQUENCY; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; MISMATCH REPAIR; MUTM GENE; MUTT GENE; MUTY GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CIPROFLOXACIN; DEOXYGUANOSINE; DNA REPAIR; DRUG RESISTANCE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MOLECULAR SEQUENCE DATA; MUTATION; PSEUDOMONAS AERUGINOSA; SEQUENCE ALIGNMENT;

EUKARYOTA; PROKARYOTA; PSEUDOMONAS AERUGINOSA;

EID: 57449105907     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2008.01411.x     Document Type: Article

References (38)

1. Akasaka T, Tanaka M, Yamaguchi A Sato K (2001) Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of flouroquinolone resistance. Antimicrob Agents Ch 45 : 2263 2268.
2. Barlow DJ Thornton JM (1988) Helix geometry in proteins. J Mol Biol 201 : 601 619.
3. Bullock WO, Fernandez JM Short JM (1987) XL1 blue: a high efficiency plasmid transforming recA Escherichia coli strain with beta-galactosidase selection. BioTechniques 5 : 376 378.
4. Campbell EA, Korzheva N, Mustaev A, Murakami K, Nair S, Goldfarb A Darst SA (2001) Structural mechanism for rifampicin inhibition of bacterial rna polymerase. Cell 104 : 901 912.
5. Cao M, Moore CM Helmann JD (2005) Bacillus subtilis paraquat resistance is directed by sigmaM, an extracytoplasmic function sigma factor, and is conferred by YqjL and BcrC. J Bacteriol 187 : 2948 2956.
6. Chopra I, O'Neill AJ Miller K (2003) The role of mutators in the emergence of antibiotic-resistant bacteria. Drug Resist Update 6 : 137 145 (Review).
7. Chuanchuen R, Beinlich K, Hoang TT, Becher A, Karkhoff-Schweizer RR Schweizer HP (2001) Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ. Antimicrob Agents Ch 45 : 428 432.
8. Ciofu O, Riis B, Pressler T, Poulsen HE Hoiby N (2005) Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation. Antimicrob Agents Ch 49 : 2276 2282.
9. David SS, O'Shea VL Kundu S (2007) Base-excision repair of oxidative DNA damage. Nature 447 : 941 950 (Review).
10. Garibyan L, Huang T, Kim M et al 2003) Use of the rpoB gene to determine the specificity of base substitution mutations on the Escherichia coli chromosome. DNA Repair 2 : 593 608.
11. Govan JR Deretic V (1996) Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60 : 539 574.
12. Hazra TK, Hill JW, Izumi T Mitra S (2001) Multiple DNA glycosylases for repair of 8-oxoguanine and their potential in vivo functions. Prog Nucleic Acid Re 68 : 193 205 (Review).
13. Higgins PG, Fluit AC, Milatovic D, Verhoef J Schmitz FJ (2003) Mutations in GyrA, ParC, MexR and NfxB in clinical isolates of Pseudomonas aeruginosa. J Antimicrob Ag 21 : 409 413.
14. Hooper DC (1998) Clinical applications of quinolones. Biochim Biophys Acta 1400 : 45 61 (Review).
15. Jacobs MA, Alwood A, Thaipisuttikul I et al 2003) Comprehensive transposon mutant library of Pseudomonas aeruginosa. P Natl Acad Sci USA 100 : 14339 14344.
16. Jalal S Wretlind B (1998) Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa. Microb Drug Resist 4 : 257 261.
17. Jalal S, Ciofu O, Hoiby N, Gotoh N Wretlind B (2000) Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob Agents Ch 44 : 710 712.
18. Jeannot K, Elsen S, Köhler T, Attree I, van Delden C Plésiat P (2008) Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump. Antimicrob Agents Ch 52 : 2455 2462.
19. Köhler T, Michea-Hamzehpour M, Plesiat P, Kahr AL Pechere JC (1997) Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa. Antimicrob Agents Ch 41 : 2540 2543.
20. Kovach ME, Elzer PH, Hill DS, Robertson GT, Farris MA, Roop RM II. Peterson KM (1995) Four new derivatives of the broad-host-range cloning vector pBBR1MCS, carrying different antibiotic-resistance cassettes. Gene 166 : 175 176.
21. Levine C, Hiasa H Marians KJ (1998) DNA gyrase and topoisomerase IV: biochemical activities, physiological roles during chromosome replication, and drug sensitivities. Biochim Biophys Acta 1400 : 29 43.
22. Lu AL, Li X, Gu Y, Wright PM Chang DY (2001) Repair of oxidative DNA damage: mechanisms and functions. Cell Biochem Biophys 35 : 141 170 (Review).
23. Maciá MD, Borrell N, Segura M, Gómez C, Pérez JL Oliver A (2006) Efficacy and potential for resistance selection of antipseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa. Antimicrob Agents Ch 50 : 975 983.
24. Maki H Sekiguchi M (1992) MutT protein specifically hydrolyses a potent mutagenic substrate for DNA synthesis. Nature 355 : 273 275.
25. Masuda N, Gotoh N, Ohya S Nishino T (1996) Quantitative correlation between susceptibility and OprJ production in NfxB mutants of Pseudomonas aeruginosa. Antimicrob Agents Ch 40 : 909 913.
26. Michaels ML, Pham L, Cruz C Miller JH (1991) MutM, a protein that prevents GC-TA transversions, is formamidopyrimidine-DNA glycosylase. Nucleic Acids Res 19 : 3629 3632.
27. Michaels ML, Tchou J, Grollman AP Miller JH (1992) A repair system for 8-oxo-7,8-dihydrodeoxyguanine. Biochemistry 31 : 10964 10968.
28. Miguel V, Monti MR Argaraña CE (2008) The role of MutS oligomers on Pseudomonas aeruginosa mismatch repair system activity. DNA Repair 7 : 1799 1808.
29. Mouneimné H, Robert J, Jarlier V Cambau E (1999) Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa. Antimicrob Agents Ch 43 : 62 66.
30. Neeley WL Essigmann JM (2006) Mechanisms of formation, genotoxicity, and mutation of guanine oxidation products. Chem Res Toxicol 19 : 491 505.
31. Oliver A, Cantón R, Campo P, Baquero F Blázquez J (2000) High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288 : 1251 1254.
32. Oliver A, Baquero F Blázquez J (2002a) The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants. Mol Microbiol 43 : 1641 1650.
33. Oliver A, Sánchez JM Blázquez J (2002b) Characterization of the GO system of Pseudomonas aeruginosa. FEMS Microbiol Lett 217 : 31 35.
34. Pezza RJ, Smania AM, Barra JL Argaraña CE (2002) Nucleotides and heteroduplex DNA preserve the active conformation of Pseudomonas aeruginosa MutS by preventing protein oligomerization. Biochem J 361 : 87 95.
35. Sambrook J, Fritsch EF Maniatis T (1989) Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
36. Smania AM, Segura I, Pezza RJ, Becerra C, Albesa I Argaraña CE (2004) Emergence of phenotypic variants upon mismatch repair disruption in Pseudomonas aeruginosa. Microbiology 150 : 1327 1338.
37. Wyrzykowski J Volkert MR (2003) The Escherichia coli methyl-directed mismatch repair system repairs base pairs containing oxidative lesions. J Bacteriol 185 : 1701 1704.
38. Yoshida H, Bogaki M, Nakamura M Nakamura S (1990) Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob Agents Ch 34 : 1271 1272.